Peringkat dalam Saham
#38304
CohBar Inc. is a clinical-stage biotechnology company dedicated to the... CohBar Inc. is a clinical-stage biotechnology company dedicated to the discovery and advancement of therapies that leverage mitochondrial biology, known as mitochondria-based therapeutics (MBTs). Their primary objective is to combat chronic conditions and diseases associated with aging. These MBTs are being developed to address a broad spectrum of medical challenges, including non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis (IPF), type 2 diabetes, acute respiratory distress syndrome (ARDS), various cancers, and cardiovascular disorders like Alzheimer's disease. Their flagship clinical asset is CB4211, an innovative, optimized analogue of the MOTS-c mitochondrial-derived peptide. This candidate is currently undergoing Phase Ib evaluation as part of a larger Phase Ia/Ib clinical trial, specifically targeting non-alcoholic steatohepatitis (NASH) and obesity. Beyond their clinical work, CohBar's preclinical portfolio features CB5138 analogs aimed at fibrotic conditions, as well as CB5064 analogs being explored for their potential in treating ARDS linked to COVID-19. Established in 2007, CohBar, Inc. maintains its corporate headquarters in Menlo Park, California.
Harga Saham
$0.41
Terakhir disinkronkan: 2025-01-23
Kapitalisasi Pasar
$1.08M
Perubahan (1 tahun)
0.00%
Perdagangan CohBar, Inc. (CWBR)
Margin Operasi untuk CohBar, Inc. (CWBR)
Margin Operasi per August 2026 TTM: 0.00%
Menurut laporan keuangan dan harga saham terbaru dari CohBar, Inc., margin operasi saat ini (TTM) adalah 0.00%. Pada akhir 2021, margin operasi perusahaan adalah 0.00%.
Riwayat margin operasi untuk CohBar, Inc. dari 2011 hingga 2026
Margin Operasi pada akhir setiap tahun
| Tahun |
Margin Operasi |
Mengubah |
|
2026 (TTM) |
0.00%
|
0.00%
|
|
2022 |
0.00%
|
0.00%
|
|
2021 |
0.00%
|
0.00%
|
|
2020 |
0.00%
|
0.00%
|
|
2019 |
0.00%
|
0.00%
|
|
2018 |
0.00%
|
0.00%
|
|
2017 |
0.00%
|
0.00%
|
|
2016 |
0.00%
|
0.00%
|
|
2015 |
0.00%
|
0.00%
|
|
2014 |
0.00%
|
0.00%
|
|
2013 |
0.00%
|
0.00%
|
|
2012 |
0.00%
|
0.00%
|
|
2011 |
0.00%
|
0.00%
|
Margin Operasi untuk perusahaan sejenis atau pesaing
| Perusahaan |
Margin Operasi |
Perbedaan Margin Operasi |
Negara |
|
|
38.97% |
-
|
US
|
|
|
28.81% |
-
|
NL
|
|
|
0.00% |
-
|
CH
|
|
|
0.00% |
-
|
KR
|
|
|
31.23% |
-
|
BE
|
Apa itu Margin Operasi perusahaan?
Margin Operasi adalah indikator utama untuk menilai profitabilitas suatu perusahaan. Margin Operasi yang lebih tinggi umumnya lebih baik karena menunjukkan bahwa perusahaan mampu menjual produk atau layanan mereka dengan harga yang jauh lebih tinggi daripada biaya produksinya. Margin Operasi dihitung dengan membagi laba perusahaan dengan pendapatannya.
